Claim Evidence review

Korro Bio will report early study results for its drug for Alpha-1 anti...

Korro Bio: Korro Bio will report early study results for its drug for Alpha-1 antitrypsin deficiency... Published Jan 2, 2025. Status: Evidence review. This st...

  • Actor: Korro Bio
  • Topic: Science
  • Status: Evidence review
  • Published: Jan 2, 2025
  • Deadline: Dec 31, 2025
Korro Bio will report early study results for its drug for Alpha-1 antitrypsin deficiency (AATD).

FactTracker assessment

This stored outcome is excluded from public accuracy until auditable verification evidence is available.

Verification rule: Event occurs: Korro Bio will report early study results for its drug for Alpha-1 antitrypsin deficiency (AATD).; window 2025-01-02 to 2025-12-31

Original source: biopharmadive.com